Customers benefit from MGS’ acceleration on delivering scalable, end-to-end healthcare manufacturing solutions and Husky’s commitment to ongoing product line advancements.
GERMANTOWN, Wis (March 11, 2025) – MGS, a global provider of healthcare product development and manufacturing solutions for leading Pharmaceutical, Diagnostic and MedTech companies, announced today the sale of its multishot product line to Husky Technologies™, a strategic supply chain partner. The sale positions MGS to expand its world-class solutions while strengthening Husky’s position as a world leader in injection molding systems.
MGS was an early pioneer in multishot technologies, building state-of-the-art injection units and rotary platens to serve its own injection molding business, as well as the need of others in the industry. Today, the company serves global healthcare innovators from 12 locations in North America and Europe with end-to-end manufacturing solutions – including product design and development, tooling, automation and manufacturing expertise.
“For decades, MGS has been at the forefront of multishot molding equipment innovations, developing high-performance, precision-engineered solutions for manufacturing facilities around the world. We knew Husky was the ideal organization to continue advancement of this innovative product line. With its commitment to delivering the highest performing, most efficient and reliable multi-material and multi-color turnkey solutions, we’re excited to continue leveraging Husky’s technologies in the future,” said Shawn Krenke, Chief Technology Officer at MGS.
The secondary injection units and rotary platens will integrate with Husky’s Altanium® mold controller technology to deliver turnkey solutions to the industry.
Both MGS and Husky are committed to ensuring a seamless transition and integration for current and future users of the multishot equipment. MGS customers will continue to benefit from ongoing multishot technology advancements, while also benefitting from MGS’ continued growth as a healthcare product development, engineering and manufacturing organization.
About MGS
Headquartered in Germantown, Wisconsin, USA, MGS is a leading end-to-end solutions provider bridging the gap between imagination and realization for healthcare innovators. For leading Pharmaceutical, Diagnostic and MedTech companies, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities – from design to fully assembly – combined with the strong customer focus and seamless collaboration of an agile partner. Customers can access these capabilities from any of the company’s 12 global locations. Learn more at mgsmfg.com.